Parallel Session – Breast, Lung Program at a glance 8:50 – 8:55 Opening Remarks Poster Display 8:55 – 9:00 Welcome Address 9:00 – 10:40 Plenary Session I 10:40 – 11:00 Coffee Break 11:00 – 12:30 Plenary Session II 12:30 – 13:30 Lunch 13:30 – 15:45 Parallel Session – Breast, Lung Parallel Session – NHL 15:45 – 16:10 16:10 – 18:30 Parallel Session – GI 18:30 – 18:40 Closing Remarks

Plenary Session 8:50 – 8:55 Opening Remarks 방영주 (서울의대) 8:55 – 9:00 Welcome Address Urs Flueckiger (Roche) Plenary Session I 좌장: 김훈교 (가톨릭의대), 김삼용 (충남의대) 9:00 – 9:30 Roche Oncology Pipeline Updates Richard Lee (Roche) 9:30 – 10:00 Cancer Biomarker Development and Personalized Treatment 김열홍 (고려의대) 10:00 – 10:40 Statistical Methods for the Analysis of Survival Data Philip McCloud (Roche) 10:40 – 11:00 Coffee Break Pleanary Session II 좌장: 박희숙 (순천향의대), 정현철 (연세의대) 11:00 – 11:30 Essential Choices in the Management of mCRC 박영석 (성균관의대) 11:30 – 12:00 Antiangiogenic Therapy in Breast Cancer 김태유 (서울의대) 12:00 – 12:30 Evolving Treatment Paradigm in Advanced NSCLC 박근칠 (성균관의대)

Parallel Session – Breast Cancer 좌장: 김시영 (경희의대), 최진혁 (아주의대) Time Topic Speaker 13:30 – 14:00 Recent Updates in the Treatment of HER2- Positive Breast Cancer 손주혁 (연세의대) 14:00 – 14:15 Preoperative Paclitaxel, Gemcitabine and Trastuzumab Chemotherapy in HER2-Positive Stage II/III Breast Cancer 이근석 (국립암센터) 14:15 – 14:30 Trastuzumab Treatment Improves Brain Metastasis Outcomes Through Control and Durable Prolongation of Systemic Extracranial Disease in HER2-Overexpressing Breast Cancer Patients 박연희 (성균관의대) 14:30 – 14:40 Clinical Experience of Antiangiogenic Therapy in Triple-Negative Metastatic Breast Cancer 박경화 (고려의대)

Parallel Session – Lung Cancer 좌장: 김주항 (연세의대), 김흥태 (국립암센터) Time Topic Speaker 14:40 – 15:10 Current Treatments and New Paradigms for Advanced NSCLC (focus on EGFR TKIs) 안명주 (성균관의대) 15:10 – 15:25 Clinical Experience of EGFR TKI in Korea I Post-Marketing Surveillance results 강진형 (가톨릭의대) 15:25 – 15:35 Clinical Experience of EGFR TKI in Korea II Case Presentation 민영주 (울산의대) 15:35 – 15:45 Clinical Experience of Antiangiogenic Therapy in ERCC-Positive NSCLC 조병철 (연세의대)

Parallel Session – GI Cancers Gastric Cancer 좌장: 강윤구 (울산의대), 이경희 (영남의대) Time Topic Speaker 16:10 – 16:40 Current Standard Chemotherapy and Future Combination of Targeted Agents in Advanced Gastric Cancer 류민희 (울산의대) 16:40 – 16:55 Capecitabine + CDDP with or without Concurrent Radiotherapy in Resected Gastric Cancer with D2 Nodal Dissection (ARTIST trial) 이지연 (성균관의대)

Parallel Session – GI Cancers Colorectal Cancer 좌장: 신동복 (가천의대), 임창열 (전북의대) Time Topic Speaker 16:55 – 17:10 Avastin-based Therapy in Clinical Practice 한세원 (서울의대) 17:10 – 17:25 Capecitabine, Oxaliplatin in Combination with Bevacizumab for the 1st line Treatment in mCRC 김태원 (울산의대) 17:25 – 17:40 PTGS2/COX2 Gene Polymorphism Associated with Prognosis for Patients with Advanced Colorectal Cancer Treated with Capecitabine and Oxaliplatin Chemotherapy 김종광 (경북의대)

Parallel Session – GI Cancers Other GI Cancers 좌장: 김준석 (고려의대), 임호영 (성균관의대) Time Topic Speaker 17:40 – 18:00 Recent Advances in the Treatment of Hepato- biliary Cancer 송홍석 (계명의대) 18:00 – 18:15 Capecitabine, Gemcitabine in Combination with Erlotinib in Pancreatic Cancer 오도연 (서울의대) 18:15 – 18:30 Capecitabine Based Chemotherapy for the Treatment of Esophageal Cancer 박연희 (성균관의대)

Parallel Session – NHL 좌장: 김철수 (인하의대), 원종호 (순천향의대) Time Topic Speaker 13:30 – 13:50 Optimal Treatment of DLCL 김민경 (영남의대) 13:50 – 14:10 Long-term Management of Relapse Patients with Follicular Lymphoma 양덕환 (전남의대) 14:10 – 14:30 Superior Treatment for Patients in 1st line CLL and Relapse CLL 이효락 (인제의대) 14:30 – 14:50 New Management of Burkitt’s Lymphoma 최철원 (고려의대)

Parallel Session – NHL (cont’d) 좌장: 조경삼 (경희의대), 홍영선 (가톨릭의대) Time Topic Speaker 14:50 – 15:05 Marginal Zone B-Cell Lymphoma in Korea 오성용 (동아의대) 15:05 – 15:20 Rituximab in Mantle Cell Lymphoma 김석진 (성균관의대) 15:20 – 15:40 New & Emerging Biologic Therapies of NHL 김효정 (한림의대) 15:40 – 16:10 Coffee Break